Standard
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5). / Schuler, E; Giagounidis, A; Haase, D; Shirneshan, K; Büsche, G; Platzbecker, U; Nolte, F; Götze, K; Schlenk, R F; Ganser, A; Letsch, A; Braulke, F; Lübbert, M; Bug, G; Schafhausen, P; Bacher, U; Gattermann, N; Wulfert, M; Haas, R; Germing, U.
in:
LEUKEMIA, Jahrgang 30, Nr. 7, 07.2016, S. 1580-2.
Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung
Harvard
Schuler, E, Giagounidis, A, Haase, D, Shirneshan, K, Büsche, G, Platzbecker, U, Nolte, F, Götze, K, Schlenk, RF, Ganser, A, Letsch, A, Braulke, F, Lübbert, M, Bug, G
, Schafhausen, P, Bacher, U, Gattermann, N, Wulfert, M, Haas, R & Germing, U 2016, '
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)',
LEUKEMIA, Jg. 30, Nr. 7, S. 1580-2.
https://doi.org/10.1038/leu.2015.340APA
Schuler, E., Giagounidis, A., Haase, D., Shirneshan, K., Büsche, G., Platzbecker, U., Nolte, F., Götze, K., Schlenk, R. F., Ganser, A., Letsch, A., Braulke, F., Lübbert, M., Bug, G.
, Schafhausen, P., Bacher, U., Gattermann, N., Wulfert, M., Haas, R., & Germing, U. (2016).
Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5).
LEUKEMIA,
30(7), 1580-2.
https://doi.org/10.1038/leu.2015.340Vancouver
Bibtex
@article{358b13c3173b43e086e13be6ede9e97b,
title = "Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)",
author = "E Schuler and A Giagounidis and D Haase and K Shirneshan and G B{\"u}sche and U Platzbecker and F Nolte and K G{\"o}tze and Schlenk, {R F} and A Ganser and A Letsch and F Braulke and M L{\"u}bbert and G Bug and P Schafhausen and U Bacher and N Gattermann and M Wulfert and R Haas and U Germing",
year = "2016",
month = jul,
doi = "10.1038/leu.2015.340",
language = "English",
volume = "30",
pages = "1580--2",
journal = "LEUKEMIA",
issn = "0887-6924",
publisher = "NATURE PUBLISHING GROUP",
number = "7",
}
RIS
TY - JOUR
T1 - Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)
AU - Schuler, E
AU - Giagounidis, A
AU - Haase, D
AU - Shirneshan, K
AU - Büsche, G
AU - Platzbecker, U
AU - Nolte, F
AU - Götze, K
AU - Schlenk, R F
AU - Ganser, A
AU - Letsch, A
AU - Braulke, F
AU - Lübbert, M
AU - Bug, G
AU - Schafhausen, P
AU - Bacher, U
AU - Gattermann, N
AU - Wulfert, M
AU - Haas, R
AU - Germing, U
PY - 2016/7
Y1 - 2016/7
U2 - 10.1038/leu.2015.340
DO - 10.1038/leu.2015.340
M3 - SCORING: Journal article
C2 - 26668126
VL - 30
SP - 1580
EP - 1582
JO - LEUKEMIA
JF - LEUKEMIA
SN - 0887-6924
IS - 7
ER -
